The American Journal of Managed Care22h
Adaptive Deep Brain Stimulation Technology Receives FDA Approval for Parkinson Disease
The ADAPT-PD trial validated aDBS's safety and efficacy, showing advantages over traditional continuous DBS methods. The ...
PharmiWeb12h
Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's
For the one million people diagnosed with Parkinson's disease in the United States1, Medtronic plc (NYSE:MDT), a global ...